John D. Grabenstein

3.7k total citations
129 papers, 2.6k citations indexed

About

John D. Grabenstein is a scholar working on Epidemiology, Health and Infectious Diseases. According to data from OpenAlex, John D. Grabenstein has authored 129 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Epidemiology, 43 papers in Health and 41 papers in Infectious Diseases. Recurrent topics in John D. Grabenstein's work include Vaccine Coverage and Hesitancy (43 papers), Influenza Virus Research Studies (33 papers) and Pneumonia and Respiratory Infections (22 papers). John D. Grabenstein is often cited by papers focused on Vaccine Coverage and Hesitancy (43 papers), Influenza Virus Research Studies (33 papers) and Pneumonia and Respiratory Infections (22 papers). John D. Grabenstein collaborates with scholars based in United States, France and Canada. John D. Grabenstein's co-authors include Abraham G. Hartzema, Mitchel C. Rothholz, Stephan L. Foster, Michael D. Hogue, Harry A. Guess, Keith P. Klugman, J. Edwin Atwood, Luwy Musey, Dimitri C. Cassimatis and James R. Neff and has published in prestigious journals such as JAMA, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

John D. Grabenstein

120 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John D. Grabenstein United States 28 1.2k 773 682 464 389 129 2.6k
Raymond A. Strikas United States 23 1.7k 1.3× 928 1.2× 611 0.9× 145 0.3× 106 0.3× 51 2.5k
Kathleen Dooling United States 26 1.5k 1.2× 1.1k 1.4× 1.4k 2.0× 171 0.4× 126 0.3× 66 3.6k
Susan van den Hof Netherlands 35 2.1k 1.7× 406 0.5× 2.3k 3.4× 316 0.7× 205 0.5× 127 3.9k
Jim McMenamin United Kingdom 34 2.3k 1.9× 755 1.0× 1.6k 2.3× 199 0.4× 85 0.2× 109 4.0k
Fiona Smaill Canada 32 2.1k 1.7× 222 0.3× 2.0k 3.0× 327 0.7× 314 0.8× 103 4.8k
T. Jacob John India 28 1.3k 1.0× 319 0.4× 1.5k 2.1× 118 0.3× 198 0.5× 179 3.0k
Richard H. Beigi United States 28 1.1k 0.9× 520 0.7× 519 0.8× 163 0.4× 102 0.3× 93 2.7k
Ian T. Williams United States 30 1.8k 1.5× 276 0.4× 1.1k 1.6× 159 0.3× 79 0.2× 45 3.6k
Evan J. Anderson United States 38 2.5k 2.1× 323 0.4× 2.1k 3.1× 358 0.8× 76 0.2× 194 4.7k
Debra Blog United States 18 1.1k 0.9× 440 0.6× 1.8k 2.7× 258 0.6× 52 0.1× 41 3.1k

Countries citing papers authored by John D. Grabenstein

Since Specialization
Citations

This map shows the geographic impact of John D. Grabenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Grabenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Grabenstein more than expected).

Fields of papers citing papers by John D. Grabenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Grabenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Grabenstein. The network helps show where John D. Grabenstein may publish in the future.

Co-authorship network of co-authors of John D. Grabenstein

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Grabenstein. A scholar is included among the top collaborators of John D. Grabenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Grabenstein. John D. Grabenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ravandi, Farhad, Sravanti Rangaraju, Hagop M. Kantarjian, et al.. (2025). A pharmacokinetic and safety study of oral arsenic trioxide in patients with acute promyelocytic leukemia. Blood Advances. 9(9). 2136–2143. 1 indexed citations
2.
Jones-Jack, Nkenge, John D. Grabenstein, Abdulhakeem Abayomi Olorukooba, et al.. (2024). Pharmacists’ answer to the COVID-19 pandemic: Contribution of the Federal Retail Pharmacy Program to COVID-19 vaccination across sociodemographic characteristics—United States. Journal of the American Pharmacists Association. 65(1). 102305–102305.
3.
Grabenstein, John D.. (2021). Vaccine humanity. Journal of the American Pharmacists Association. 62(1). 286–287. 1 indexed citations
4.
Ciprero, Karen L., Rocio D. Marchese, Patrick O. Richard, et al.. (2016). Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes. Human Vaccines & Immunotherapeutics. 12(8). 2135–2141. 3 indexed citations
5.
O’Brien, Megan A., et al.. (2013). Cost-Effectiveness Of Pneumococcal Vaccines For Adults In The United States. Value in Health. 16(3). A93–A93. 1 indexed citations
6.
7.
Grabenstein, John D. & Keith P. Klugman. (2012). A century of pneumococcal vaccination research in humans. Clinical Microbiology and Infection. 18. 15–24. 74 indexed citations
8.
Grabenstein, John D.. (2006). The Value of Immunization for God’s People. The National Catholic Bioethics Quarterly. 6(3). 433–442. 1 indexed citations
9.
Ford, Stephen M. & John D. Grabenstein. (2006). Pandemics, Avian Influenza A (H5N1), and a Strategy for Pharmacists. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(3). 312–322. 15 indexed citations
10.
Norton, Scott A., et al.. (2006). Analysis of cases reported as generalized vaccinia during the US military smallpox vaccination program, December 2002 to December 2004. Journal of the American Academy of Dermatology. 55(1). 23–31. 10 indexed citations
11.
Hogue, Michael D., John D. Grabenstein, Stephan L. Foster, & Mitchel C. Rothholz. (2006). Pharmacist Involvement with Immunizations: A Decade of Professional Advancement. Journal of the American Pharmacists Association. 46(2). 168–182. 204 indexed citations
12.
Grabenstein, John D.. (2006). Immunization to Protect the US Armed Forces: Heritage, Current Practice, and Prospects. Epidemiologic Reviews. 28(1). 3–26. 78 indexed citations
13.
Olmsted, Stuart S., et al.. (2005). Use of an Electronic Monitoring System for Self-Reporting Smallpox Vaccine Reactions. Biosecurity and Bioterrorism Biodefense Strategy Practice and Science. 3(3). 198–206. 14 indexed citations
14.
Cassimatis, Dimitri C., et al.. (2004). Smallpox vaccination and myopericarditis: a clinical review. Journal of the American College of Cardiology. 43(9). 1503–1510. 129 indexed citations
15.
Wasserman, Glenn M., et al.. (2003). Analysis of Adverse Events after Anthrax Immunization in US Army Medical Personnel. Journal of Occupational and Environmental Medicine. 45(3). 222–233. 47 indexed citations
16.
Grabenstein, John D., et al.. (2002). Attitudinal factors among adult prescription recipients associated with choice of where to be vaccinated1. Journal of Clinical Epidemiology. 55(3). 279–284. 38 indexed citations
17.
Grabenstein, John D.. (2000). Side Effects of Vaccination: A Consumer's Guide to Cause and Effect. Hospital Pharmacy. 35(12). 1308–1318. 1 indexed citations
18.
Grabenstein, John D.. (1999). Lyme Disease: Geography Predicts Risk. Journal of the American Pharmaceutical Association (1996). 39(1). 86–91.
19.
Grabenstein, John D.. (1998). Pharmacists as vaccine advocates: roles in community pharmacies, nursing homes, and hospitals. Vaccine. 16(18). 1705–1710. 66 indexed citations
20.
Grabenstein, John D., et al.. (1992). Community Pharmacists as Immunization Advocates. Medical Care. 30(6). 503–513. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raymond A. Strikas Breakdown of academic impact, for papers by Kathleen Dooling Breakdown of academic impact, for papers by Susan van den Hof Breakdown of academic impact, for papers by Jim McMenamin Breakdown of academic impact, for papers by Fiona Smaill Breakdown of academic impact, for papers by T. Jacob John Breakdown of academic impact, for papers by Richard H. Beigi Breakdown of academic impact, for papers by Ian T. Williams Breakdown of academic impact, for papers by Evan J. Anderson Breakdown of academic impact, for papers by Debra Blog
Rankless by CCL
2026